gentian violet has been researched along with HIV Coinfection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Evans, S; Freedberg, KA; Ghannoum, MA; Hakim, J; Kumwenda, J; Lee, A; Masheto, G; Mukherjee, PK; Patton, LL; Pho, MT; Salata, RA; Sawe, F; Shiboski, CH | 1 |
| Maree, JE; Sibanyoni, M; Wright, SC | 1 |
| Ghannoum, MA; Jurevic, RJ; Mukherjee, PK; Salata, RA; Traboulsi, RS | 1 |
| Coogan, M; Fidel, PL; Ghannoum, M; Komesu, M; Leigh, JE; McCullough, M; Patton, LL | 1 |
| Chandra, J; Ghannoum, MA; Jurevic, R; Mukherjee, PK; Salata, RA; Traboulsi, RS | 1 |
| Cu-Uvin, S; Gallo, MF; Jamieson, DJ; Rompalo, AM; Schoenbaum, E; Sobel, JD | 1 |
| Arellano, L; Lozano, C; Yaquich, P | 1 |
| Jin, Y; Samaranayake, LP; Samaranayake, YH; Yau, JY; Yip, HK | 1 |
| Chen, HY; Cohen, MH; Sha, BE; Spear, GT; Wang, QJ; Zariffard, MR | 1 |
| Cupić, M; Jevtović, D; Jovanović, T; Knezević, A; Ranin, J; Stepanović, S | 1 |
| Arbiser, JL; Bhandarkar, SS; Fried, L; MacKelfresh, J | 1 |
| Anderson, J; Brown, W; Cu-Uvin, S; Duerr, A; Holmberg, S; Jamieson, DJ; Kieke, B; Klein, RS; Mayer, K; Schuman, P; Sobel, J; Warren, D | 1 |
1 review(s) available for gentian violet and HIV Coinfection
| Article | Year |
|---|---|
[Human intestinal spirochetosis: clinical series and literature review].
Topics: Aged; Brachyspira; Chile; Chronic Disease; Diarrhea; Female; Gentian Violet; Gram-Negative Bacterial Infections; HIV Infections; Humans; Intestinal Diseases; Male; Middle Aged; Phenazines; Prevalence | 2012 |
3 trial(s) available for gentian violet and HIV Coinfection
| Article | Year |
|---|---|
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Drug-Related Side Effects and Adverse Reactions; Female; Gentian Violet; Health Care Costs; HIV Infections; Humans; Male; Middle Aged; Nystatin; Single-Blind Method; Treatment Outcome; Young Adult | 2017 |
Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Oral; Citrus; Cymbopogon; Female; Gentian Violet; HIV Infections; Humans; Male; Mouth; Phytotherapy; Plant Leaves; Plant Preparations; South Africa; Treatment Outcome | 2009 |
Identification of gentian violet concentration that does not stain oral mucosa, possesses anti-candidal activity and is well tolerated.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Oral; Gentian Violet; HIV Infections; Human Experimentation; Humans; Mouth Mucosa; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2011 |
8 other study(ies) available for gentian violet and HIV Coinfection
| Article | Year |
|---|---|
New approaches to Candida and oral mycotic infections: Workshop 2A.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Developing Countries; Disease Progression; Focus Groups; Gentian Violet; HIV Infections; Humans; Immunocompromised Host; Infant, Newborn; Infant, Newborn, Diseases; Mouthwashes; Pigmentation Disorders; Viral Load; Virulence Factors | 2011 |
Gentian violet exhibits activity against biofilms formed by oral Candida isolates obtained from HIV-infected patients.
Topics: Anti-Infective Agents, Local; Biofilms; Candida albicans; Candidiasis, Oral; Dose-Response Relationship, Drug; Gentian Violet; HIV Infections; Humans; Microscopy, Confocal | 2011 |
Discordance between spermatozoa detection and self-reported semen exposure.
Topics: Adolescent; Adult; Condoms; Female; Gentian Violet; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Phenazines; Prospective Studies; Risk Factors; Risk-Taking; Self Report; Semen; Sexual Behavior; Sexually Transmitted Diseases; Spermatozoa; Surveys and Questionnaires; United States; Young Adult | 2011 |
Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Biofilms; Candida albicans; Candidiasis, Oral; Carrier State; Gentian Violet; HIV Infections; Humans; Oxidation-Reduction; Tetrazolium Salts | 2003 |
Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.
Topics: DNA, Bacterial; Female; Gardnerella vaginalis; Gentian Violet; HIV; HIV Infections; Humans; Lactobacillus; Mycoplasma hominis; Phenazines; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity; Vaginal Smears; Vaginosis, Bacterial | 2005 |
Reduced quantity and hydrogen-peroxide production of vaginal lactobacilli in HIV positive women.
Topics: Adult; Case-Control Studies; Female; Gentian Violet; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Hydrogen Peroxide; Lactobacillus; Middle Aged; Phenazines; Prevalence; Vagina | 2005 |
Targeted therapy of oral hairy leukoplakia with gentian violet.
Topics: Adult; Gentian Violet; HIV Infections; Humans; Leukoplakia, Hairy; Male | 2008 |
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Cross-Sectional Studies; Female; Gentian Violet; HIV Infections; Humans; Middle Aged; Odds Ratio; Phenazines; Prevalence; Risk Factors; Vaginosis, Bacterial | 2001 |